articleControlled Clinical TrialsJan 30, 2004Closed access

Assessment of blinding in clinical trials

HBHeejung BangLNLiyun NiCDC.E. Davis

University of North Carolina at Chapel Hill · Amgen (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

655
total citations
FWCI
7.71
Percentile
100%
References
20
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Blinding
  • Clinical trial
  • Medicine
  • Double blind
  • Alternative medicine
  • Placebo
  • Internal medicine
  • Pathology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding